Scientists have launched a trial screening programme in the UK for type 1 diabetes which, they say, “could transform the way the condition is identified and managed in its earliest stages”.
Around 20,000 children, aged three to 13 years, are being invited to take part in the Early Surveillance for Autoimmune Diabetes (Elsa) study, with recruitment opening on Monday.
